Anaerobutyricum soehngenii is the first live, gut-native bacterium of its kind to receive a positive EFSA safety opinion under the EU Novel Food Regulation, an important step toward reaching European consumers. DELFT, the Netherlands, 1 September 2026. Caelus welcomes...
EMIH member Mikrobiomik has announced that EUTEGRA® (MBK-01), its microbiota-based therapy for recurrent Clostridioides difficile infection (CDI), has been authorized in Spain under the National Spanish Substances of Human Origin (SoHO) framework (the SoHO Regulation...
Launched by EMIH and prepared by a committee of microbiome experts (members of EMIH), this first-of-its-kind bootcamp is designed as a practical, transdisciplinary and highly participative event. Over two days, industry leaders, product developers, academic...
Biofortis announces that it has obtained authorization from the French National Agency for the Safety of Medicines and Health Products (ANSM) for its activities involving the collection of human stool samples intended for the preparation of fecal microbiota for...
The Biocodex Microbiota Institute is pleased to highlight the launch of a new CME-accredited online course, “The Gut Microbiome in Immuno-Oncology”, now available on the Xpeer platform. This course is led by Dr. Arielle Elkrief, medical oncologist and...
